scispace - formally typeset
M

Min Li

Researcher at Hong Kong Baptist University

Publications -  281
Citations -  13367

Min Li is an academic researcher from Hong Kong Baptist University. The author has contributed to research in topics: Autophagy & Medicine. The author has an hindex of 41, co-authored 217 publications receiving 9848 citations. Previous affiliations of Min Li include Changsha Medical University & Tokai University.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

CXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling.

TL;DR: Bioinformatic analysis and clinical investigation suggested that high CXCL1 expression is significantly correlated with breast cancer lymph node metastasis, poor overall survival and basal-like subtype, and CxCL1-based therapy might become a novel strategy for breast cancer metastasis prevention.
Journal ArticleDOI

Calcium signaling in Alzheimer's disease & therapies.

TL;DR: Current knowledge on the molecular mechanisms linking Ca2+ dysregulation with AD pathologies is summarized and the possibility of correcting neuronal Ca1+ disruption as a therapeutic approach for AD is discussed.